Experiencing the cancer of a loved one influences decision-making for breast cancer prevention

被引：10

作者：

Padamsee, Tasleem J. ^{[1
]}

Muraveva, Anna ^{[1
]}

Yee, Lisa D. ^{[2
]}

Wills, Celia E. ^{[1
]}

Paskett, Electra D. ^{[1
]}

机构：

[1] Ohio State Univ, Cunz Hall,1841 Neil Ave, Columbus, OH 43210 USA

[2] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA

来源：

JOURNAL OF HEALTH PSYCHOLOGY | 2020年 / 25卷 / 08期

关键词：

breast cancer prevention; chemoprevention; family history; high-risk women; qualitative research; risk-reducing surgery; HEREDITARY BREAST; WOMEN; CHEMOPREVENTION; ADHERENCE; IMPACT; RISK;

D O I：

10.1177/1359105317746480

中图分类号：

B849 [应用心理学];

学科分类号：

040203 ;

摘要：

Prior research demonstrates that family history influences breast cancer prevention decisions among healthy women at elevated risk of the disease. Drawing on in-depth interviews with 50 African American and White women, this study reveals an important psychological mechanism of this relationship: exposure to cancer among loved ones. Four distinct categories of cancer exposure (Abstract, Generalized, Practical, and Traumatic), distinguished by the characteristics of women's experiences with cancer among family members and close friends, are associated with differences in knowledge and decisions about breast cancer prevention options. Racial differences and distinct experiences among those withBRCAmutations are also discussed.

引用

页码：1064 / 1075

页数：12

共 50 条

[21] Preferences and actual chemotherapy decision-making in the greater plains collaborative breast cancer study
Berger, Ann M.
Buzalko, Russell J.
Kupzyk, Kevin A.
Gardner, Bret J.
Djalilova, Dilorom M.
Otte, Julie L.
ACTA ONCOLOGICA, 2017, 56 (12) : 1690 - 1697
[22] Decision-making for bilateral risk-reducing mastectomy for an increased lifetime breast cancer risk: A qualitative metasynthesis
Torrisi, Christa
Wareg, Nuha K.
Anbari, Allison Brandt
PSYCHO-ONCOLOGY, 2024, 33 (03)
[23] Does mainstream BRCA testing affect surgical decision-making in newly-diagnosed breast cancer patients?
Ain, Quratul
Richardson, Caroline
Mutebi, Miriam
George, Angela
Kemp, Zoe
Rusby, Jennifer E.
BREAST, 2023, 67 : 30 - 35
[24] Decision making for breast cancer prevention among women at elevated risk
Padamsee, Tasleem J.
Wills, Celia E.
Yee, Lisa D.
Paskett, Electra D.
BREAST CANCER RESEARCH, 2017, 19
[25] Distribution and influence of the 21-gene recurrence score on chemotherapy decision-making in special type of breast cancer
Yu, Jing
Wu, Jiayi
Huang, Ou
He, Jianrong
Zhu, Li
Chen, Weiguo
Li, Yafen
Chen, Xiaosong
Shen, Kunwei
AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (12): : 6188 - +
[26] Breast Cancer Prevention: Patient Decision Making and Risk Communication in the High Risk Setting
Ozanne, Elissa M.
Wittenberg, Eve
Garber, Judy E.
Weeks, Jane C.
BREAST JOURNAL, 2010, 16 (01) : 38 - 47
[27] Treatment decision-making, family influences, and cultural influences of Chinese breast cancer survivors: a qualitative study using an expressive writing method
Wang, Lijuan
Geng, Xiaotao
Ji, Lili
Lu, Guohua
Lu, Qian
SUPPORTIVE CARE IN CANCER, 2020, 28 (07) : 3259 - 3266
[28] Shared decision-making - Rhetoric and reality: Women's experiences and perceptions of adjuvant treatment decision-making for breast cancer
Mahmoodi, Neda
Sargeant, Sally
JOURNAL OF HEALTH PSYCHOLOGY, 2019, 24 (08) : 1082 - 1092
[29] A prospective decision-impact study incorporating Breast Cancer Index into extended endocrine therapy decision-making
Sanft, Tara
Berkowitz, Alyssa
Schroeder, Brock
Hatzis, Christos
Schnabel, Catherine A.
Brufsky, Adam
Gustavsen, Gary
Pusztai, Lajos
van Londen, G. J.
BREAST CANCER MANAGEMENT, 2019, 8 (01)
[30] Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals
Rainey, Linda
van der Waal, Danielle
Donnelly, Louise S.
Evans, D. Gareth
Wengstrom, Yvonne
Broeders, Mireille
PLOS ONE, 2018, 13 (06):

← 1 2 3 4 5 →